Brain tumour management is determined by tumour type, grade, location, and the patient’s neurological status. Surgery is the primary intervention for most accessible tumours maximum safe resection reduces tumour burden, relieves pressure, and obtains tissue for histological and molecular diagnosis. Radiation and chemotherapy follow based on pathology. Low-grade tumours in non-eloquent locations may be observed before surgery in select cases. High-grade gliomas require immediate multimodal treatment. Getting the diagnosis right is the first step in getting the treatment right.
According to Dr. Gurneet Singh Sawhney, one of the best neurosurgeon in Mumbai, “How well a patient does after a brain tumour diagnosis depends heavily on how early surgery happens and how much tumour is removed safely the molecular result from that specimen shapes everything that follows.”
Recently diagnosed with a brain tumour and unclear on what treatment sequence applies to your case?
What Treatment Options Are Available for Brain Tumour Patients?
The surgical approach for all resectable tumours follows the same intraoperative planning standards used in brain surgery for eloquent-area lesions.
How Patients Manage Recovery and Ongoing Monitoring After Treatment?
Treatment doesn’t end at surgery or the last radiation session recovery and surveillance are active clinical phases.
- Steroid management: Dexamethasone controls peri-tumoural oedema before and after surgery. The goal is tapering to the minimum effective dose as quickly as the neurological picture allows prolonged use produces myopathy, immunosuppression, and hyperglycaemia.
- Seizure control: Up to 30% of brain tumour patients develop seizures. Levetiracetam is preferred over enzyme-inducing drugs like phenytoin because it doesn’t accelerate temozolomide clearance or reduce efficacy during concurrent chemoradiation.
- Rehabilitation: Physiotherapy, occupational therapy, speech therapy, and neuropsychological rehabilitation address functional deficits from surgery and tumour. Starting early consistently produces better outcomes and neuroplasticity is highest in the first months after surgery.
- Surveillance imaging: Post-treatment MRI every two to three months is standard for high-grade tumours. Functional neurosurgery follow-up protocols use the same cadence to distinguish true progression from pseudoprogression, which can appear identical on standard contrast MRI.
Recurrence planning starts at diagnosis: patients who understand second-line options are better positioned to act quickly when surveillance imaging changes. For symptom patterns that prompt initial diagnosis, see brain tumour warning signs.
Why Choose Dr. Gurneet Singh Sawhney?
Dr. Gurneet Singh Sawhney holds MBBS, MS (General Surgery), and MCh (Neurosurgery) ranking first in the MCh university examination with specialised expertise in Neuro-oncology and Neuroendoscopy, fellowship training in Functional Neurosurgery from Japan, and over 18 years of surgical experience managing primary and metastatic brain tumours across all grades using awake craniotomy, intraoperative fluorescence guidance, and cortical mapping.
His brain tumour practice reviews molecular pathology before adjuvant treatment is planned because the surgical specimen result, not the imaging grade, determines what happens next.
Frequently Asked Questions
Is surgery always the first treatment for a brain tumour?
In most accessible tumours yes surgery provides diagnosis and reduces tumour burden before adjuvant therapy begins.
Does MGMT methylation status affect brain tumour treatment?
Yes MGMT methylation predicts temozolomide response and directly determines adjuvant chemotherapy intensity.
How often is MRI done after brain tumour treatment?
High-grade tumours require surveillance MRI every two to three months post-treatment to detect early recurrence.
Can a brain tumour patient develop seizures during treatment?
Yes up to thirty percent of patients develop seizures, requiring antiepileptic medication compatible with chemotherapy.
Disclaimer: The information shared in this content is for educational purposes only and not for promotional use.